Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9C5T4 | — |
somebody administer a Shingrix vaccine without reconstitute it, they just use the liquid, and not the lyophilized gE antigen component; somebody administer a Shingrix vaccine without reconstitute it, they just use the liquid, and not the lyophilized gE antigen component; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old male patient who received Herpes zoster (Shingrix) (batch number 9C5T4, expiry date 26-OCT-2026) for prophylaxis. Previously administered products included Shingrix (received 1st dose of vaccine on 14th November 2024). On 17-JAN-2025, the patient received the 2nd dose of Shingrix. On 17-JAN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: somebody administer a Shingrix vaccine without reconstitute it, they just use the liquid, and not the lyophilized gE antigen component) and inappropriate dose of vaccine administered (Verbatim: somebody administer a Shingrix vaccine without reconstitute it, they just use the liquid, and not the lyophilized gE antigen component). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 30-JAN-2025 Reporter called from a clinic, and they provided a vaccine for a patient. He/she was doing the inventory management for the month for vaccines, and it looked like someone administered a Shingrix vaccine without reconstituting it. They just used the liquid and not the lyophilized gE antigen component, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. He/she was told by his/her manager that he/she needed to call and find out from what they needed to do. Healthcare professional reported that the 1st complete Shingrix dose was administered on 14th November 2024, then this 2nd dose (only the liquid portion) was on 17th January 2025.